Together with the extensive tumor necrosis and pronounced inflammatory infiltrates, these findings show that the combined inhibition of DDR1 and chemotherapy produces the most potent antitumor effect, likely through an augmented immune-mediated response. The gene discussed is DDR1; the disease is neoplasm.